Literature DB >> 34956485

A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method.

Xuefeng Ma1, Chao Yang2, Kun Liang2, Baokai Sun1, Wenwen Jin1, Lizhen Chen1, Mengzhen Dong1, Shousheng Liu3, Yongning Xin1, Likun Zhuang3.   

Abstract

Diagnostic markers for non-alcoholic fatty liver disease (NAFLD) are still needed for screening individuals at risk. In recent years, the machine learning method was used to search for the diagnostic markers of multiple diseases. In this study, we developed and validated a machine learning model to diagnose NAFLD using laboratory indicators. NAFLD patients and non-NAFLD controls were recruited in the training and validation cohorts. The laboratory indicators of the participants in the training cohort were collected, and six indicators including alanine aminotransferase/aspartate aminotransferase (ALT/AST), white blood cells (WBC), alpha-L-fucosidase (AFU), hemoglobin (Hb), triglycerides (TG) and gamma-glutamyl transpeptidase (GGT) were screened out with higher weights by an integrate machine learning method. The areas under the receiver operating characteristic curves (AUROCs) for the selected indicators using logistic regression (LR), random forest (RF) and support vector machine (SVM) were 0.814, 0.837 and 0.810, respectively. Then the binary logistic regression was used to construct the predictive model. What's more, the AUROC of the predicted model was 0.732 in the validation cohort of patients with NAFLD. And the combined AUROC of the six parameters was 0.716 in the mouse model fed with high-fat diet (HFD). In summary, we created a predictive model with six laboratory indicators for the diagnosis of NAFLD based on the machine learning method, which has the potential value for the diagnosis of the NAFLD. AJTR
Copyright © 2021.

Entities:  

Keywords:  NAFLD; diagnosis; laboratory indicator; machine learning

Year:  2021        PMID: 34956485      PMCID: PMC8661138     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  43 in total

1.  Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.

Authors:  Xiaoli Liu; Yixin Hou; Xinhui Wang; Lihua Yu; Xianbo Wang; Li Jiang; Zhiyun Yang
Journal:  Hepatol Int       Date:  2020-06-18       Impact factor: 6.047

2.  Relationship between white blood cell count and nonalcoholic fatty liver disease.

Authors:  Yong-Jae Lee; Hye-Ree Lee; Jae-Yong Shim; Byung-Soo Moon; Jung-Hyun Lee; Jong-Koo Kim
Journal:  Dig Liver Dis       Date:  2010-05-15       Impact factor: 4.088

3.  The relationship between cell membrane damage and lipid peroxidation under the condition of hypoxia-reoxygenation: analysis of the mechanism using antioxidants and electron transport inhibitors.

Authors:  Daisuke Yajima; Hisako Motani; Mutsumi Hayakawa; Yayoi Sato; Kaoru Sato; Hirotaro Iwase
Journal:  Cell Biochem Funct       Date:  2009-08       Impact factor: 3.685

Review 4.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

5.  Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

Authors:  Zhen-Ya Lu; Chao Cen; Zhou Shao; Xin-Hua Chen; Cheng-Fu Xu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

Review 6.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

7.  Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.

Authors:  P Tangkijvanich; P Tosukhowong; P Bunyongyod; S Lertmaharit; O Hanvivatvong; P Kullavanijaya; Y Poovorawan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-03       Impact factor: 0.267

8.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

9.  Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver.

Authors:  Paola Dongiovanni; Luca Valenti; Anna Ludovica Fracanzani; Stefano Gatti; Gaetano Cairo; Silvia Fargion
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

10.  Multiparametric ultrasomics of significant liver fibrosis: A machine learning-based analysis.

Authors:  Wei Li; Yang Huang; Bo-Wen Zhuang; Guang-Jian Liu; Hang-Tong Hu; Xin Li; Jin-Yu Liang; Zhu Wang; Xiao-Wen Huang; Chu-Qing Zhang; Si-Min Ruan; Xiao-Yan Xie; Ming Kuang; Ming-De Lu; Li-Da Chen; Wei Wang
Journal:  Eur Radiol       Date:  2018-09-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.